2022
Epidemiology, burden, and attributable risks of infective endocarditis in Iran and its provinces: From 1990 to 2019
Ajam A, Shobeiri P, Keykhaei M, Moghaddam S, Momtazmanesh S, Masinaei M, Esfahani Z, Rezaei N, Naderian M, Aminorroaya A, Rashidi M, Rezaei N, Larijani B, Malakan Rad E, Farzadfar F. Epidemiology, burden, and attributable risks of infective endocarditis in Iran and its provinces: From 1990 to 2019. International Journal Of Cardiology 2022, 363: 202-209. PMID: 35777487, DOI: 10.1016/j.ijcard.2022.06.060.Peer-Reviewed Original ResearchConceptsAge-standardized mortality ratesAge-standardized incidence rateAge-standardized prevalence rateDisability-adjusted life yearsAge-standardized DALY rateMortality rateInfectious disease associated with significant morbidityDALY ratesRisk of infective endocarditisDisease associated with significant morbidityGlobal burdenIncidence rateLife yearsPrevalence ratesEscalating incidenceAge groupsStudy dataInfective endocarditisEpidemiological indicesBurdenSignificant morbidityGBDEndocarditisMortalityProvincial level
2019
Global, Regional and National Burden of Bladder Cancer, 1990 to 2016: Results from the GBD Study 2016.
Ebrahimi H, Amini E, Pishgar F, Moghaddam S, Nabavizadeh B, Rostamabadi Y, Aminorroaya A, Fitzmaurice C, Farzadfar F, Nowroozi M, Black P, Daneshmand S. Global, Regional and National Burden of Bladder Cancer, 1990 to 2016: Results from the GBD Study 2016. Journal Of Urology 2019, 201: 893-901. PMID: 30676477, DOI: 10.1097/ju.0000000000000025.Peer-Reviewed Original ResearchConceptsMortality-to-incidence ratioAge-standardized ratesBladder cancer burdenCancer burdenIncident casesAge-standardized incidence rateGlobal Burden of Disease StudyBladder cancer risk factorsBurden of Disease StudyCancer deathCancer incident casesComparative risk assessment frameworkBurden of bladder cancerCancer risk factorsAge-standardized incidenceStandardized incidence rateDisability adjusted life yearsStandard rateStandard life expectancyVital registration systemsHigher fasting plasma glucoseBladder cancer deathYears of lifeHigher fasting glucoseBladder cancer